4234932
Last Update Posted: 2020-04-14
Recruiting status is unknown
All Genders accepted | 18 Years + |
10 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
Investigate changes in optical coherence tomography angiography of the optic nerve and macula following topical instillation of commercial preparations of netarsudil 0.02% ophthalmic solution.
Eligibility
Relevant conditions:
Glaucoma, Open-Angle
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
Mary Jo Bilicek
bilicek@uiwtx.edu
210-805-3565
Data sourced from ClinicalTrials.gov